Syniverse and Telefónica Collaborate to Offer New Secure Global Messaging Service
28.10.2019 10:05:00 EET | Business Wire | Press release
At the GSMA WAS#10 conference and exposition, Syniverse, the world’s most connected company, announced it is developing a secure global messaging solution that is designed to help brands keep text messaging clear of inherent security risks that come when sending messages over the internet and without proper user authentication.
To protect against vulnerabilities in text messaging, Syniverse is collaborating with Telefónica to offer businesses a global cloud-based messaging platform that runs over a private network with end-to-end encryption of actual messages and messages in transit. The network operates separately from the public internet using private addressing schemes that make it invisible to those with malicious intent.
What used to be considered “secure enough” for text messaging is no longer adequate for keeping information safe from the advanced techniques of fraudsters and hackers. That’s why companies like Telefónica International in Latin America and Europe are turning to Syniverse to help manage mobile communications by confirming customer identity and consent, and securely transmitting customer and business data.
The mobile attack rate in Latin America, where the Syniverse solution will initially launch, is 8.9 percent, according to Lexis Nexis. Payment transactions, logins and new account creations are being targeted by fraudulent bots, and by the spoofing of internet protocol (IP) addresses, devices and identities. With this secure global messaging solution, Syniverse and Telefónica will protect customers and mobile operators from these attacks as well as an array of other cyberattacks, including phishing, whaling, denial-of-service, and man-in-the-middle incidents.
Latin America isn’t the only region that’s targeted by malicious actors. In the U.S. last year, there were 16.7 million people affected by account takeover fraud, according to Javelin Research. In one case, a leading bank lost $15 million in fraudulent withdrawals due to poor transport, application and security encryptions. Attackers fraudulently assumed the identity of one of the bank’s customers to access the payment network before making fake withdrawals from multiple bank branches.
The need for the secure alternative that Syniverse will offer extends beyond the banking industry. The potential for loss affects any company that relies on digital communications. Text messages can be hacked to access financial or operational information or even to control networks, systems and databases. Whether it’s an e-commerce platform that sends one-time password texts to authenticate customers or a government agency deploying surveillance drones, a variety of processes used by different industries are at risk.
Syniverse will safeguard the customer experience and drastically decrease business risks by offering full-network-layer encryption all the way through a company application to the mobile operator with segmenting isolation in two areas. Also, automated alarming will set off if network end points deviate from expected communications behavior.
Product availability will be based on the number of mobile network operators connected to the secure global messaging solution, which will continually expand. Companies looking to secure their communications can contact Syniverse here.
CLICK TO TWEET : .@Syniverse & @telefonicab2b collaborate to make #textmessaging safer from hackers and fraudsters #enterprises. #cybersecurity #fraud @GSMA #WAS10 http://ow.ly/ZT8q50wUcpQ
Quote
- John Wick, Senior Vice President and General Manager, Global Product, Syniverse
“Any device that is capable of sending and receiving text messages over an unsecured network is at risk of cyberattack. To minimize this risk, Syniverse and Telefónica are leading the way to secure the messaging environment so that sensitive information is protected at each stage of its journey as a message is sent from a brand, passed through a mobile network, and received by an end device.”
Supporting Resources
- Read about GSMA WAS#10.
- Read about Telefónica.
- Read about Syniverse.
- Read about Syniverse secure global messaging solution.
- Read about John Wick.
- Read and subscribe to Syniverse Blog.
- Read and subscribe to Syniverse news releases.
- For more information about Syniverse’s news and activities, and follow the company on Twitter, LinkedIn and Facebook.
About Syniverse
Syniverse is the world’s most connected company – we pioneer innovations that take business further. Our secure, global network reaches billions of people and devices. Our engagement platform powers the customized experiences of the future. And the millions of secure transactions we drive every minute are revolutionizing how goods and services are exchanged. We have always led companies to reimagine the boundaries of possibility. Today we’re delivering on opportunities with the power to change the world.
About Telefonica Business Solutions
Telefónica Business Solutions a leading provider of a wide range of integrated communication solutions for the B2B market, manages globally the Enterprise (Large Enterprise and SME), MNC (Multinational Corporations), Wholesale (fixed and mobile carriers, ISPs and content providers) and Roaming businesses within the Telefónica Group. Business Solutions develops an integrated, innovative and competitive portfolio for the B2B segment including digital solutions (Big Data, Cloud, IoT or Security) and telecommunication services (international voice, IP, bandwidth capacity, satellite services, mobility, integrated fixed, mobile, IT services and global solutions). Telefonica Business Solutions is a multicultural organization, working in over 40 countries and with service reach in over 170 countries.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191028005117/en/
Contact information
Kevin Petschow
Syniverse
+1.813.637.5084
kevin.petschow@syniverse.com
Matt Burrows
The Hoffman Agency (for Syniverse)
+1.408.286.2611
mburrows@hoffman.com
Telefónica
Corporate Communications Department
+34 91 482 3800
prensatelefonica@telefonica.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
